Ahmed Eldefrawy

Medium-term Outcomes of Active Surveillance for Localised Prostate Cancer

Outcomes of initially expectantly managed patients with low or intermediate risk screen‐detected localized prostate cancer

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

Epidemiology of chronic kidney disease: an update 2022

Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study

Performance Characteristics of MR Imaging in the Evaluation of Clinically Low-Risk Prostate Cancer: A Prospective Study

ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee

PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2

Baseline Attitudes About Prostate Cancer Screening Moderate the Impact of Decision Aids on Screening Rates

Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?

EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013

Decision aids for people facing health treatment or screening decisions

The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation

Hemodialysis Disparities in African Americans: The Deeply Integrated Concept of Race in the Social Fabric of Our Society

Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer

Careful Selection and Close Monitoring of Low-Risk Prostate Cancer Patients on Active Surveillance Minimizes the Need for Treatment

Factors That Influence Patient Enrollment in Active Surveillance for Low-risk Prostate Cancer

Disparities Among Blacks, Hispanics, and Whites in Time From Starting Dialysis to Kidney Transplant Waitlisting